Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza receives positive EU CHMP opinion for use in germline BRCA-mutated HER2-negative advanced breast cancer
-
Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer
-
Brilinta’s Phase III THEMIS trial met primary endpoint in patients with established coronary artery disease and type-2 diabetes
-
Full-Year 2018 Results
-
US FDA grants Fasenra Orphan Drug Designation for hypereosinophilic syndrome
-
US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897
-
EMA grants PRIME eligibility for potential next-generation RSV medicine MEDI8897
-
Forxiga receives positive EU CHMP opinion for the treatment of adults with type-1 diabetes
-
Linzess (linaclotide) approved in China for the treatment of irritable bowel syndrome with constipation
-
AstraZeneca announces organisational changes
Latest articles and press releases
All of our latest press releases and articles are available to explore
